Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - lansoprazolum - capsule - lansoprazolum 30 mg, excipiens pro capsula. - peptisches ulcera, reflusso gastrico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - lansoprazolum - capsule - lansoprazolum 15 mg, excipiens pro capsula. - peptisches ulcera, reflusso gastrico - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - le compresse gastroresistenti di - pantoprazolum 40.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 6.75 mg. - inibitori della pompa protonica - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - pantoprazolum - le compresse gastroresistenti di - pantoprazolum 20.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 3.38 mg. - inibitori della pompa protonica - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - anagrelidum - capsule rigide - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum k 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (nigrum), pro capsula. - trattamento della trombocitemia essenziale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - agalsidasum alfa - infusionskonzentrat - agalsidasum alfa 1 mg, natrii dihydrogenophosphas monohydricus, polysorbatum 20, natrii chloridum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.1 mg. - enzymersatz terapia nei pazienti con malattia di fabry (alfa-galattosidasi a mancanza) - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 10 mg; retardkapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum 34.1-49.5 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 20 mg; retardkapseln - methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 68.2-99.7 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 30 mg; retardkapseln - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 102.3-149.8 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - idursulfasum - infusionskonzentrat - idursulfasum 2 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.7 mg. - trattamento a lungo termine dei pazienti con hunter-sindrome (mucopolisaccaridosi ii, mps ii) - biotechnologika